News
Centene Swings to 2Q Loss, Sees Further Membership Declines for Medicaid, Medicare
The managed-care specialist's troubles began in April when its quarterly results were overshadowed by membership declines in Medicaid and Medicare. Centene in July then withdrew its financial guidance for 2025 after warning that its earnings would fall well short of expectations.
Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing ...
The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...
Health coverage company Centene (NYSE:CNC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales ...
Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...
Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety ...
In its second quarter, the Clayton-based company lost $253 million dollars, 51 cents a share. In the same period last year, ...
Centene is trading at half of book value and under 9x earnings, an extreme undervaluation for a cash-generating insurer. See ...
Intel (NASDAQ: INTC) stock slumped 8% after the chipmaker forecast steeper losses than expected in the third quarter and ...
In the case of Centene, which is trading at $34.57 as of publishing time, $100 would buy you 2.89 shares of stock. If you're looking to bet against a company, the process is more complex.
Shares of Centene ( NYSE: CNC) lost ~10% in the premarket on Friday after the Medicaid-driven managed care firm fell short of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback